Evoke Pharma, Inc. (EVOK) NASDAQ

5.40

+0.28(+5.47%)

Updated at August 18 03:16PM

Currency In USD

Evoke Pharma, Inc.

Address

420 Stevens Avenue

Solana Beach, CA 92075

United States of America

Phone

858 345 1494

Sector

Healthcare

Industry

Drug Manufacturers - Specialty & Generic

Employees

3

First IPO Date

September 25, 2013

Key Executives

NameTitlePayYear Born
Mr. Matthew J. D'Onofrio MBACo-Founder, Chief Executive Officer & Director990,6011970
Mr. Mark A. Kowieski CPAChief Financial Officer, Treasurer & Secretary598,4381978
Dr. Marilyn R. Carlson D.M.D., M.D., RAC.Chief Medical Officer630,1321948
Mr. Christopher QuesenberryChief Commercial Officer - Gimoti (TM)0N/A

Description

Evoke Pharma, Inc., a specialty pharmaceutical company, primarily focuses on the development and commercialization of drugs for the treatment of gastroenterological disorders and diseases. It is developing Gimoti, a metoclopramide nasal spray that has completed Phase 3 clinical trials to treat symptoms associated with acute and recurrent diabetic gastroparesis in females. The company markets its products to gastroenterologists, internal medicine specialists, primary care physicians, and select health care providers. Evoke Pharma, Inc. was incorporated in 2007 and is headquartered in Solana Beach, California.